Abstract
Prokaryotes have adaptive defence mechanisms that protect them from mobile genetic elements and viral infection. One defence mechanism is called CRISPR–Cas (clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins). There are six different types of CRISPR–Cas systems and multiple subtypes that vary in composition and mode of action. Type I and III CRISPR–Cas systems utilise multi-protein complexes, which differ in structure, nucleic acid binding and cleaving preference. The type I-D system is a chimera of type I and III systems. Recently, there has been a burst of research on the type I-D CRISPR–Cas system. Here, we review the mechanism, evolution and biotechnological applications of the type I-D CRISPR–Cas system.
Cite
CITATION STYLE
McBride, T. M., Cameron, S. C., Fineran, P. C., & Fagerlund, R. D. (2023, April 1). The biology and type I/III hybrid nature of type I-D CRISPR–Cas systems. Biochemical Journal. Portland Press Ltd. https://doi.org/10.1042/BCJ20220073
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.